This inventor holds 21 USPTO granted patents and 1 published patent application, primarily in Factor Xa Inhibitors. Top assignees: Bristol-Myers Squibb Pharma Company, Dupont Pharmaceuticals Company, Bristol-Myers Squibb Compnay. Active years: 1994-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
8 out of 234 
4 out of 106 
3 out of 3,742 
Years Active: 1994-2007
Areas of Expertise:
Title: The Innovative Journey of James Russell Pruitt
Introduction
James Russell Pruitt, an accomplished inventor based in Landenberg, Pennsylvania, has contributed significantly to the field of pharmaceuticals with a total of 21 patents to his name. His innovative work primarily focuses on the development of compounds that have potential therapeutic applications, particularly in treating diseases such as diabetes and obesity.
Latest Patents
Among his latest patents, one titled "Guanidine mimics as factor Xa inhibitors" describes compounds with nitrogen-containing heteroaromatics that act as inhibitors of factor Xa. This innovative application is crucial in the development of therapeutic agents targeting coagulation processes. Another notable patent is "Inhibitors of proteins that bind phosphorylated molecules," which introduces compounds capable of modulating target protein activities, specifically phosphatases that interact with phosphorylated peptides or proteins. These inventions are key to advancing treatments for various diseases linked to protein activity.
Career Highlights
James has had a remarkable career, having worked with prominent companies in the pharmaceutical sector, including Bristol-Myers Squibb and DuPont Pharmaceuticals. His experiences at these leading firms have undoubtedly shaped his innovative mindset and contributed to his impressive portfolio of patents.
Collaborations
Throughout his career, James has had the privilege to collaborate with talented professionals such as Mimi Lifen Quan and John Matthew Fevig. These collaborations have fostered an environment of shared knowledge and innovation, further enhancing the quality and impact of his inventions.
Conclusion
James Russell Pruitt stands out as a remarkable inventor whose contributions to the pharmaceutical industry continue to pave the way for advancements in therapeutic treatments. With his extensive patent portfolio and collaborative efforts, he remains a significant figure in the realm of innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile